Trending:
Analysis
-
![]()
The highs and lows of hormone replacement therapy
Hormone replacement therapy for women at menopause has been beset with issues over the past few decades, from safety concerns to drug shortages and rising costs. What are the challenges...
-
![World Menopause Month]()
World Menopause Month: moving from HRT to non-hormonal therapies
World Menopause Month, which runs throughout October, raises awareness of menopause and associated disorders and diseases. The standard of care for menopause symptoms is hormone replacement therapy, but as this...
-
![Sandoz]()
September’s top news stories
Novartis signed an agreement to sell parts of its Sandoz US business to Aurobindo Pharma USA for $900m, and the California Department of Insurance filed a lawsuit against AbbVie for...
-
![]()
Gene and cell therapies: making manufacturing work
Gene and cell therapies are potentially revolutionary, but complex science and manufacturing issues could hold them back in the market. We speak to Dr Pascale Bouillé of France-based Flash Therapeutics,...
-
![Masters Speciality Pharma]()
Masters Speciality Pharma: bringing high-quality drugs to emerging markets
Masters Speciality Pharma seeks to correct the side-lining of the developing world in terms of quality pharmaceutical products by distributing drugs formulated and manufactured in the developed world to emerging...
-
![pharma and the environment]()
Pharma and the environment: pollution continues despite public pressure
The negative impact of the production of pharmaceutical products on the natural environment is well known. However, this remains largely unregulated, meaning the extremely toxic impact it has on both...
-
![]()
Pharma Technology Focus – Special Issue
In this issue: Manufacturing personalised medicine, the economics of CAR-T treatments, AI in drug combination therapy and more.
-
![orphan drugs]()
CHMP recommends 13 new drugs for European approval
The EMA’s CHMP has recommended 13 medicines, including three orphan drugs, for marketing approval by the European Commission, as well as confirming its earlier negative guidance on Sarepta’s Exondys. The...
-
![]()
Amazon and PillPack: an unstoppable pharmacy force?
After months of speculation over Amazon’s ambitions in the healthcare space, news broke in June that the online retail juggernaut had bought PillPack, a US-based online pharmacy. The move rattled...
-
![top ten clinical research organisations]()
Ranking the top ten clinical research organisations in the world
Clinical research organisations assist drug manufacturers during the clinical trial process to improve efficiency and speed. Igea Hub has created a ranking system for clinical research organisations primarily based on...
